Login
Super Investors iShares Russell 2000 Growth ETF

iShares Russell 2000 Growth ETF

Ishares Trust · net assets $15.4B · 1137 holdings as of June 30, 2026. Monthly N-PORT disclosure: the full book, not just equities.

Asset mix

EC: 87.1% · STIV: 12.9% · OTHER: 0.0% · DE: 0.0%

Financial position

Total assets
$17.7B
Total liabilities
$2.28B
Net assets
$15.4B
Assets attributable to miscellaneous securities
$0
Assets invested in controlled foreign corporations
$0
Borrowings payable within one year
$0
Payable to controlled companies within one year
$0
Payable to other affiliates within one year
$0
Other liabilities payable within one year
$0
Borrowings payable after one year
$0
Payable to controlled companies after one year
$0
Payable to other affiliates after one year
$0
Other liabilities payable after one year
$0
Payables for delayed-delivery investments
$0
Payables for standby commitments
$0
Liquidation preference of outstanding preferred stock
$0
Cash not reported in Parts C or D
$53.2M

Monthly flows and gains

Month 1 Month 2 Month 3
Sales $276M $350M $614M
Reinvestment $0 $0 $0
Redemptions $287M $364M $422M
Net realized gain (non-derivative) $128M $159M $1.78B
Net unrealized appreciation (non-derivative) $1.64B $643M $-1.26B

The three months of the reporting period, as filed; month 3 ends June 30, 2026.

Filing details

Registrant
Ishares Trust
Registrant CIK
1100663
Registrant LEI
5493000860OXIC4B5K91
Series
iShares Russell 2000 Growth ETF
Series ID
S000004343
Series LEI
549300CPJOUVKWJGSH44
SEC file number
811-09729
Address
400 Howard Street, San Francisco, US-CA, 94105, US
Phone
800-474-2737
Form
NPORT-P
Filed
August 25, 2026
Report period ends
March 31, 2027
Report month ends
June 30, 2026
Accession number
000207169126019776
Holding Value % of net assets
Blackrock Funds Iii STIV $2.28B 14.75%
Moog, Inc. EC $112M 0.73%
Brightspring Health Services, Inc. EC $105M 0.68%
Maxlinear, Inc. EC $102M 0.66%
Argan, Inc. EC $101M 0.66%
Jfrog Ltd. EC $91.6M 0.59%
Krystal Biotech, Inc. EC $89.7M 0.58%
Esco Technologies, Inc. EC $85.6M 0.56%
Firstcash Holdings, Inc. EC $82.3M 0.53%
D-wave Quantum, Inc. EC $81.8M 0.53%
Stonex Group, Inc. EC $79.7M 0.52%
Praxis Precision Medicines, Inc. EC $78.1M 0.51%
Cipher Digital, Inc. EC $76.8M 0.50%
Plexus Corp. EC $75.2M 0.49%
Enersys EC $75.1M 0.49%
Ryman Hospitality Properties, Inc. EC $74.5M 0.48%
Glaukos Corp. EC $74.4M 0.48%
Tg Therapeutics, Inc. EC $73.8M 0.48%
Federal Signal Corp. EC $72.5M 0.47%
Myr Group, Inc. EC $72.4M 0.47%
Zurn Elkay Water Solutions Corp. EC $70.8M 0.46%
Healthequity, Inc. EC $70.8M 0.46%
Enpro, Inc. EC $70.3M 0.46%
Kodiak Gas Services, Inc. EC $70.1M 0.45%
Compass, Inc. EC $69.8M 0.45%
Protagonist Therapeutics, Inc. EC $69.6M 0.45%
Hims & Hers Health, Inc. EC $69.2M 0.45%
Interdigital, Inc. EC $68.3M 0.44%
Brinker International, Inc. EC $67.5M 0.44%
Silicon Laboratories, Inc. EC $66.9M 0.43%
Lantheus Holdings, Inc. EC $66.9M 0.43%
Archrock, Inc. EC $65.7M 0.43%
Alkermes PLC EC $64.7M 0.42%
Core Scientific, Inc. EC $64.6M 0.42%
Kulicke & Soffa Industries, Inc. EC $64.1M 0.42%
Mercury Systems, Inc. EC $63.7M 0.41%
Oscar Health, Inc. EC $63.5M 0.41%
Acm Research, Inc. EC $63.2M 0.41%
Nuvalent, Inc. EC $61.3M 0.40%
Spyre Therapeutics, Inc. EC $61M 0.40%
Riot Platforms, Inc. EC $59.8M 0.39%
Cogent Biosciences, Inc. EC $59.6M 0.39%
Ultra Clean Holdings, Inc. EC $59.2M 0.38%
Twist Bioscience Corp. EC $59M 0.38%
Commvault Systems, Inc. EC $58.6M 0.38%
Ligand Pharmaceuticals, Inc. EC $58.6M 0.38%
Granite Construction, Inc. EC $58.4M 0.38%
Hut 8 Corp. EC $58M 0.38%
Materion Corp. EC $57.6M 0.37%
Casella Waste Systems, Inc. EC $57.2M 0.37%
Rhythm Pharmaceuticals, Inc. EC $56.6M 0.37%
Rigetti Computing, Inc. EC $56.4M 0.37%
Definium Therapeutics, Inc. EC $55.9M 0.36%
Joby Aviation, Inc. EC $55.8M 0.36%
Apogee Therapeutics, Inc. EC $55.3M 0.36%
Axcelis Technologies, Inc. EC $54.9M 0.36%
Kymera Therapeutics, Inc. EC $54.8M 0.36%
Xenon Pharmaceuticals, Inc. EC $54.7M 0.35%
Victoria's Secret & Co. EC $54.4M 0.35%
Novanta, Inc. EC $54.4M 0.35%

Showing top 60 of 1137 holdings.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support